drugset / Trial / NCT00847080
Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism
Phase 4
Completed
20 enrolled
National Institute of Medical Sciences and Nutrition Salvador Zubiran
Merck Sharp & Dohme LLC · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether sitagliptin is effective in the treatment of reactive hypoglycemia by dysinsulinism.
Timeline
- Start
- 2008-12
- Primary completion
- 2010-12
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | 100 mg | — |